Shuoshi Biotech announced that Liang Xilin, the limited partner of the company's controlling shareholder Leung Kang Biotech, filed a lawsuit with the court requesting the dissolution of Leung Kang Biotech. The case is in the processing stage and has not yet been tried in court. As of the announcement date, Runkang Biotech held 34,1702.4 million shares of the company, accounting for 27.53% of the total share capital. The company operates independently and is currently operating normally. This lawsuit has not affected the company's profits. However, if the court upholds the plaintiff's request, it may lead to changes in the company's controlling shareholders and actual controllers, and the company will closely monitor the progress and promptly disclose it.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.